No Data
No Data
Shuyu Pingmin (301017): Steady increase in revenue, continued expansion of store layout
Revenue grew steadily, and profits were under pressure in the short term. Maintaining “buy” rating companies achieved revenue of 9.191 billion yuan in 2023 (+17.49% year over year; the following are all year-on-year ratios); net profit to mother was 133 million yuan (-42.
Shuyu Pingmin (301017.SZ): Net profit of 10.5082 million yuan in the first quarter decreased by 83.72% year on year
Gelonghui, April 26, 丨 Shu Yu Ping Min (301017.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 2,439 billion yuan, up 17.69% year on year; net profit attributable to shareholders of listed companies was 10.5082 million yuan, down 83.72% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 9.5085 million yuan, down 84.25% year on year; basic earnings per share were 0.03 yuan.
Shuyu Pingmin (301017.SZ): Currently, there are no sales of doughnut products
Gelonghui, April 10 | Shuyu Pingmin (301017.SZ) said on the investor interactive platform that the company currently has no sales of doughui products. The company's health food category covers a variety of nutritional supplements and functional foods to meet consumers' health needs.
Medical beauty stocks fell collectively. Among them, Jiangsu Wuzhong fell to a standstill, Aimeike fell more than 9%, Jingfeng Pharmaceutical fell more than 5%, Huadong Pharmaceutical, Betaini, and Guanhao Biotech fell more than 4%, and Teyi Pharmaceutica
Medical beauty stocks fell collectively. Among them, Jiangsu Wuzhong fell to a standstill, Aimeike fell more than 9%, Jingfeng Pharmaceutical fell more than 5%, Huadong Pharmaceutical, Betaini, and Guanhao Biotech fell more than 4%, and Teyi Pharmaceutical, Shuyu Pingmin, Changshan Pharmaceutical, and Dian Diagnosis fell more than 3%.
Shuyu Pingmin (301017.SZ): Initial repurchase of 246,800 shares involving 3.620,900 yuan
Gelonghui, Feb. 26丨Shuyu Pingmin (301017.SZ) announced that on February 26, 2024, the company carried out its first repurchase through a centralized bidding transaction through a special securities account for share repurchases. The number of repurchases was 246.841 million shares, accounting for 0.06% of the current total share capital. The highest transaction price was 14.73 yuan/share, the lowest transaction price was 14.37 yuan/share, and the total transaction amount was RMB 3,6209.37 million (excluding transaction fees).
Shuyu Pingmin (301017.SZ): Plans to spend 40 million yuan to 60 million yuan to buy back the company's shares
Gelonghui, Feb. 19: Shuyu Pingmin (301017.SZ) announced that the company plans to use its own funds to repurchase some of the RMB common stock (A shares) shares already issued by the company through centralized bidding transactions. The repurchased shares are used to protect the company's value and shareholders' rights, and all of the repurchased shares will be sold in accordance with relevant regulations. The total amount of the repurchase capital is not less than RMB 40 million (inclusive) and not more than RMB 60 million (inclusive). The specific amount of shares to be repurchased is based on the actual repurchase amount when the repurchase is completed. The source of the repurchase funds is the company's own funds. The repurchase price is not more than 18 yuan
No Data